Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirill Peskov

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|August 11, 2025
A Systematic Comparative Analysis of Tumor Size Models Based on Erlotinib Clinical Data in Advanced NSCLCAnna Mishina, Kirill Zhudenkov, Gabriel Helmlinger, et al.
Frontiers in Immunology|March 12, 2024
An integrative mechanistic model of thymocyte dynamicsVictoria Kulesh, Kirill Peskov, Gabriel Helmlinger, et al.
Journal of Bioinformatics and Computational Biology|October 23, 2008
Kinetic modeling of ace operon genetic regulation in Escherichia coliKirill Peskov, Igor Goryanin, Klaus Prank, et al.
Frontiers in Immunology|May 18, 2026
Quantitative systems pharmacology model of B cell immune response in mouseYaroslav Ugolkov, Alina Volkova, Gabriel Helmlinger, et al.
Frontiers in Pharmacology|May 27, 2026
Niraparib PBPK modeling to predict optimal dosage in patients with hepatic impairmentAnatoly Pokladyuk, Veronika Voronova, Gabriel Helmlinger, et al.
Frontiers in Cardiovascular Medicine|February 2, 2024
Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies-a model-based meta-analysisAlina Volkova, Boris Shulgin, Gabriel Helmlinger, et al.
Frontiers in Oncology|September 28, 2020
Quantification of Scheduling Impact on Safety and Efficacy Outcomes of Brain Metastasis Radio- and Immuno-Therapies: A Systematic Review and Meta-AnalysisVeronika Voronova, Svetlana Lebedeva, Marina Sekacheva, et al.
Pharmaceutics|February 27, 2026
Systematic Review and Model-Based Meta-Analysis of Targeted Drugs for Systemic SclerosisMarina Vaskeikina, Yaroslav Ugolkov, Boris Kireev, et al.
Microbiology Spectrum|April 12, 2022
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19Yuri Kosinsky, Kirill Peskov, Donald R Stanski, et al.
Frontiers in Immunology|May 29, 2019
Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-OncologyKirill Peskov, Ivan Azarov, Lulu Chu, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
CPT: Pharmacometrics & Systems Pharmacology|August 11, 2025
A Systematic Comparative Analysis of Tumor Size Models Based on Erlotinib Clinical Data in Advanced NSCLCAnna Mishina, Kirill Zhudenkov, Gabriel Helmlinger, et al.
Frontiers in Immunology|March 12, 2024
An integrative mechanistic model of thymocyte dynamicsVictoria Kulesh, Kirill Peskov, Gabriel Helmlinger, et al.
Journal of Bioinformatics and Computational Biology|October 23, 2008
Kinetic modeling of ace operon genetic regulation in Escherichia coliKirill Peskov, Igor Goryanin, Klaus Prank, et al.
Frontiers in Immunology|May 18, 2026
Quantitative systems pharmacology model of B cell immune response in mouseYaroslav Ugolkov, Alina Volkova, Gabriel Helmlinger, et al.
Frontiers in Pharmacology|May 27, 2026
Niraparib PBPK modeling to predict optimal dosage in patients with hepatic impairmentAnatoly Pokladyuk, Veronika Voronova, Gabriel Helmlinger, et al.
Frontiers in Cardiovascular Medicine|February 2, 2024
Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies-a model-based meta-analysisAlina Volkova, Boris Shulgin, Gabriel Helmlinger, et al.
Frontiers in Oncology|September 28, 2020
Quantification of Scheduling Impact on Safety and Efficacy Outcomes of Brain Metastasis Radio- and Immuno-Therapies: A Systematic Review and Meta-AnalysisVeronika Voronova, Svetlana Lebedeva, Marina Sekacheva, et al.
Pharmaceutics|February 27, 2026
Systematic Review and Model-Based Meta-Analysis of Targeted Drugs for Systemic SclerosisMarina Vaskeikina, Yaroslav Ugolkov, Boris Kireev, et al.
Microbiology Spectrum|April 12, 2022
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19Yuri Kosinsky, Kirill Peskov, Donald R Stanski, et al.
Frontiers in Immunology|May 29, 2019
Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-OncologyKirill Peskov, Ivan Azarov, Lulu Chu, et al.
Pageof 5